Diabetes Mellitus, Inflammatory Response, Metabolic Syndrome
Conditions
Keywords
ADIPOSE TISSUE, CARDIOVASCULAR, OBESE PATIENTS
Brief summary
This study evaluates the relationship between the adipose tissue, as an active component, which can define metabolic phenotypes linked to cardiovascular risk modification post bariatric surgery.
Detailed description
Bariatric surgery induces a significant reduction in co-morbidities associated with obesity, such as Diabetes mellitus, dyslipidemia, liver disease, arterial hypertension, obstructive apnea and cardiovascular risk. However this does not happen in all obese patients, even when there is a weight reduction. It is known that the adipose tissue is actively involved in synthesis of cytokines and its role in metabolic phenotypes has been suggested. It is possible that the intrinsic mechanisms of adipose tissue participate in several benefits observed in morbidly obese patients who undergo to an anti-obesity surgery. So this study explores the involvement of adipose tissue as an active component, which can define metabolic phenotypes linked to cardiovascular risk modification post bariatric surgery.
Interventions
PROCEDUREBariatric surgery
There are two components to the procedure. First, a small stomach pouch, approximately one ounce or 30 milliliters in volume, is created by dividing the top of the stomach from the rest of the stomach. Next, the first portion of the small intestine is divided, and the bottom end of the divided small intestine is brought up and connected to the newly created small stomach pouch. The procedure is completed by connecting the top portion of the divided small intestine to the small intestine further down so that the stomach acids and digestive enzymes from the bypassed stomach and first portion of small intestine will eventually mix with the food.
Sponsors
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Above 18 years old. * Morbid obese patients candidates to bariatric surgery.
Exclusion criteria
* Second bariatric surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluate the association of the cardiovascular benefit of the obese patient after bariatric surgery with the basic mechanisms of adipose tissue (metabolic profile) | 3 years | Evaluate the association of the cardiovascular benefit of the obese patient after bariatric surgery with the basic mechanisms of adipose tissue (metabolic profile) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Correlation between serum concentration of pro-inflammatory biomarker and the reduction of subclinical endothelial disfunction. | 9 months | measurements of carotid intima-media thickness (CIMT) in millimeter and Flow mediated dilatation (FMD) in percent in a basal time and see over time the reduction (if any) of those endothelial markers |
| Determine the association of the cardiovascular prognosis modification (risk subgroups) with the basal metabolic profile. | 9 months | After the 9 months follow up, the authors will correlated the pro-inflammatory cytokines, presence or absence of adipose proteins. |
Outcome results
None listed